Filing Details

Accession Number:
0001144204-17-044724
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-23 15:22:51
Reporting Period:
2017-08-23
Accepted Time:
2017-08-23 14:22:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1137883 Brainstorm Cell Therapeutics Inc. BCLI Biological Products, (No Disgnostic Substances) (2836) 207273918
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1608814 Uri Yablonka C/O Brainstorm Cell Therapeutics, Inc.
3 University Plaza Drive, Suite 320
Hackensack NJ 07601
Evp & Chief Business Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-23 2,000 $3.98 7,543 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct